Dr Daniel Pan

NIHR Doctoral Research Fellow/Honorary Specialist Registrar in Infectious Diseases and General Internal Medicine

Dr Daniel Pan

School/Department: Respiratory Sciences, Department of


Address: Office 524 Robert Kilpatrick Clinical Sciences Building Leicester Royal Infirmary LE1 5WW




Dr Daniel Pan is a PhD Candidate and NIHR Doctoral Research Fellow at the Department of Respiratory Sciences, NIHR Leicester Biomedical Research Centre and Development Centre for Population Health. He is also an honorary Specialist Registrar in Infectious Diseases and General Internal Medicine at University Hospitals of Leicester NHS Trust. 

Dan studied Medicine at Imperial College London and completed Core Medical Training in Yorkshire, London and the East Midlands.  During the COVID-19 pandemic, Dan was part of a group that was the first to identify that COVID-19 was disproportionately affecting ethnic minority groups and disentangled the potential mechanisms that could explain these differential outcomes. He is part of the UK-REACH study team -a national study led by the University of Leicester that has one of the largest and most comprehensive longitudinal datasets on healthcare workers in the UK.

Dan's latest research focus is in infectious disease epidemiology. As part of his PhD he designed and implemented large field studies of SARS-CoV-2 transmission in the community and within hospital. Within COVID-MASK, Dan led the first study to detect and quantify exhaled SARS-CoV-2 longitudinally in exhaled breath using facemask sampling, and quantify its associations with household transmission. COVID-MASK has recruited over 600 participants since 2020. His latest research focuses on modes of respiratory virus transmission, SARS-CoV-2 vaccine effectiveness and immunity to infections a both individual and population levels. He has strong links with the Oxford Big Data Institute and the Hong Kong School of Public Health.

Dan has led on international guidelines in collaboration with the World Health Organisation on the ethnic disparities in health due to COVID-19. His work has been used as debate within the UK House of Commons. He is NIHR trainee representative for the East Midlands and a Fellow of the Royal Society for Public Health and the Royal Statistical Society.

He has more than 100 publications; including 25 articles with 25 or more citations (h-index of 25). In 2021, Dan was named by Forbes' magazine as one of Europe's top '30 under 30' innovators in healthcare for his research and clinical contributions to the COVID-19 pandemic. In 2024, Dan was awarded a Turner-Warwick lectureship from the Royal College of Physicians (RCP) for his work on transmission dynamics of SARS-CoV-2 and its implications for healthcare workers. He is the first award recipient to give the Turner-Warwick Lecture twice, in two different subject areas (Cardiology and Infectious Diseases). 


I am an academic trainee in infectious diseases and general internal medicine, and am interested in translational aspects of respiratory infection.

The major focus of my research work to date has been in COVID-19; its disproportionate effect in ethnic minority groups and the transmission dynamics of the virus, SARS-CoV-2. The longitudinal viral load kinetics of SARS-CoV-2 in different compartments, such as saliva, nasopharynx and exhaled breath, and how these relate to how infectious someone may be to others (their infectivity) remains unclear. My previous work and that of co-workers has drawn attention to the importance of quantifying infectivity accurately – so that interventions, such as antivirals, or self-isolation can be implemented or de-escalated in a more personalised approach. Furthermore, we have shown the importance of disentangling the risk factors for infection (ie, exposure to a pathogen) from the risk factors for developing severe disease once infected (which may be more biological) for disproportionately affected subgroups such as those from ethnic minority groups.

I am now a NIHR Doctoral Research Fellow at the University of Leicester, within the Centre for Population Health and Department of Respiratory Sciences. In my PhD, I aim to develop new tools to refine the risk stratification of the infectivity of individuals with acute SARS-CoV-2, using a combination of epidemiological and laboratory approaches. The work has 3 components.

1) Evaluation of existing tools (lateral flow assays, nasopharnygeal swabs, saliva sampling) for evaluation of infectivity

2) Assessment of the feasibility and ability of facemask sampling (which samples virus in exhaled breath) for evaluation of infectivity

3) Mathematical modelling to map out intra-host viral load and relation to infectivity. 

My continuing interest is in further understanding of host infectivity for SARS-CoV-2 and implications for possible therapeutic strategies. My strengths as an investigator are as a clinical scientist. 

For a list of my publications, please visit my ORCID ID


Original research papers (*joint first authorship)

  1. Antoun I, Alkhayer A, Kotb A...Pan D. The prevalence and prognostic value of diabetes and hypertension in patients treated for cholera during the ongoing Syrian conflict. Clinical Infection in Practice 2024
  2. Chaka A*, Pan D*, Irshad M et al. Inclusion of racial and ethnic groups in clinical trials for COVID-19 and post-acute COVID-19 syndrome: an analysis of studies registered on Journal of Infection 2024
  3. Ekezie W, Martin CA, Baggaley RF….Pan D…Pareek M. Association between ethnicity and migration status with the prevalence of single and multiple long-term conditions in UK healthcare workers. BMC Medicine 2023
  4. Martin CA, Medisauskaite A, Gogi M…Pan D…Pareek M. Attrition of the healthcare workforce and its association with discrimination and feeling undervalued: a cross-sectional analysis from the UK-REACH study. The Lancet 2023
  5. Wilson NM, Calabria C, Warren A…Pan D. Quantifying hospital environmental ventilation using carbon dioxide monitoring - a multicentre study. Anaesthesia 2023
  6. Irizar P, Kapadia D, Amele S…Pan D, Pareek M. Pathways to ethnic inequalities in COVID-19 health outcomes in the United Kingdom: a systematic map. Social Science and Medicine 2023
  7. Pan D, Atkinson B, Decker J et al. Concomitant, consecutive self-obtained facemask and swab samples from exhaled breath, pox lesions, nasopharynx and the face in patients recovering from mpox – a longitudinal sampling study. Journal of Infection 2023
  8. McBridge M, Martin CA, Teece L…Pan D…Pareek M. Worsening financial concerns lead to symptoms of depression in healthcare workers: a longitudinal cohort study from UK-REACH. British Journal of Psychiatry Open 2023
  9. Liu X, Munro APS, Wright A…Pan D…Faust S. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial. Journal of Infection 2023
  10. Martin CA, Nazareth J, Jarkhi A, Pan D et al. Ethnic differences in cellular and humoral immune responses to SARS-CoV-2 vaccination in UK healthcare workers: a cross-sectional analysis. EClinicalMedicine 2023
  11. Iriza P*, Pan D*, Kapadia D et al. Ethnic inequalities in COVID-19 infection, hospitalisation, intensive care admission and death: a global systematic review and meta-analysis of over 200 million study participants. EClinicalMedicine 2023
  12. Bird P, Pan D, Martin CA. et al. Awareness of HIV, Hepatitis B, Hepatitis C, Tuberculosis and COVID-19 in migrant students in the UK- A pilot survey from an Institute of Higher Education. Journal of Infection 2023
  13. Nazareth J*, Pan D*, Kim JW et al. Discriminatory ability of gas chromatography-ion mobility spectrometry to identify patients hospitalised with COVID-19 and predict prognosis. Open Forum Infectious Diseases 2022
  14. Veli N, Martin CA, Woolf K…Pan D…Pareek M. Hesitancy for receiving regular SARS-COV-2 vaccination in UK healthcare workers: a cross sectional analysis from the UK-REACH study. BMC Infectious Diseases 2022
  15. Medina M, Nazareth J, Dillion HM…Pan D…Pareek, M. Respiratory virus transmission using a novel viral challenge model: an observational cohort study. Journal of Infection 2022
  16. Pan D, Williams CM, Decker J et al. Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission. Clinical Microbiology and Infection 2022
  17. Williams CM, Muhammad AK, Sambou B…Pan D…Sutherland JS. Exhaled Mycobacterium tuberculosis predicts incident infection in household contacts. Clinical Infectious Diseases 2022
  18. Qureshi I, Gogoi M, Wobi F…Pan D…Pareek M et al. Healthcare workers from diverse ethnicities and their perceptions of risk and experiences of risk management during the COVID-19 pandemic: Qualitative insights from the UK-REACH study. Frontiers in Medicine 2022
  19. Martin CA*, Pan D*, Nazareth J* et al. Access to personal protective equipment in healthcare workers during the COVID-19 pandemic in the United Kingdom: results from a nationwide cohort study (UK-REACH) BMC Health Services Research 2022
  20. Martin CA, Pan D, Melbourne C et al. Risk factors associated with SARS-CoV-2 infection in a mult-ethnic cohort of United Kingdom healthcare workers (UK-REACH): a cross-sectional analysis. PLOS Medicine 2022
  21. Akbar S*, Pan D*, Ehdode A et al. Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19. Journal of Infection 2022
  22. Martin CA*, Pan D*, Hills G et al. Predictors of adverse outcome in the first and second waves of the COVID-19 pandemic: results from a UK centre. Therapeutic Advances in Infectious Disease 2022
  23. Martin CA, Woolf K, Bryant L…Pan D…Pareek M. Persistent hesitancy for SARS-CoV-2 vaccines among healthcare workers in the United Kingdom: analysis of longitudinal data from the UK-REACH cohort study The Lancet Regional Health Europe 2022
  24. Pan D*, Kim JW*, Nazareth J* et al. Quantification and prognostic significance of interferon-γ secreting SARS-CoV-2 responsive T cells in hospitalised patients with acute COVID-19. Journal of Infection 2021
  25. Munro APS, Janani L, Cornelius V…Pan D…Faust SN. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. The Lancet 2021
  26. Liu X, Munro APS, Feng S…Pan D…Faust SN. Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial. Journal of Infection 2022
  27. Dejnirattisai W, Huo J, Zhou D…Pan D…Screaton GR. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell 2022
  28. Nazareth J, Barr I, Sullivan SG…Pan D…Pareek M. Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients. Journal of Infection 2022
  29. Cuthbert JJ, Brown OI, Urbinati A, Pan D…Clark AL. Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF. European Heart Journal Acute Cardiovascular Care 2021
  30. Munro APS, Janani L, Cornelius V…Pan D…Faust SN. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. The Lancet 2021
  31. Barker J*, Pan D*, Koeckerling D et al. Effect of serial awake prone positioning on oxygenation in patients admitted to intensive care with COVID-19. Postgraduate medical journal 2021
  32. Williams C*, Pan D*. Decker J et al. Exhaled SARS-CoV-2 quantified by face-mask sampling in patients admitted to hospital with COVID-19. Journal of Infection 2021
  33. Pan D, Pellicori P, Dobbs K et al. Prognostic value of the chest x-ray in patients hospitalised for heart failure. Clinical Research in Cardiology 2021
  34. Sze S*, Pan D*, Nevill CR* et al. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2020
  35. Deep A, Upadyay G, Due Pre P…Pan D… Ramnarayan P. Acute Kidney Injury in Paediatric Inflammatory Multisystem Syndrome temporally associated with Severe Acute Respiratory Syndrome Coronavirus-2 pandemic: experience from PICUS across United Kingdom. Critical Care 2020
  36. Pan D, Hills G, Hamilton AR et al. Recommended antimicrobial therapy for common inpatient infections: a comparative review of guidelines across 51 hospital trusts in England. Postgraduate Medical Journal 2020
  37. Martin CA, Jenkins DR, Minhas JS…Pan D…Pareek M. Socio-demographic heterogeneity in the prevalence of COVID-19 during lockdown is associated with ethnicity and household size: results from an observational study. EClinicalMedicine 2020
  38. Pan D*, Sze S*, Minhas JS et al. The impact of ethnicity on clinical outcomes in COVID-19: A systematic review. EClinicalMedicine 2020
  39. Pan D, Pellicori P, Walklett C et al. Driving habits and reaction times on a driving simulation in older drivers with chronic heart failure. Journal of Cardiac Failure 2020
  40. NL Mudalige, Sze S, Oyegeso O…Pan D. To PPE or not to PPE? Making sense of conflicting international recommendations for PPE during chest compressions in patients with COVID-19.  Resuscitation 2020
  41. Pan D, Sze S, Rogers B et al. Serial simultaneously self-swabbed samples from multiple sites show similarly decreasing SARS-CoV-2 loads in COVID-19 cases of differing clinical severity. Journal of Infection 2020
  42. Arkell P, Pan D, Riley P et al. Should prospective renal transplant recipients be screened for Strongyloides stercoralisClinical Kidney Journal 2020
  43. Sze S, Pan D, Williams CML et al. Variability but not admission or trends in NEWS-2 score predicts clinical outcome in elderly hospitalised patients with COVID-19. Journal of Infection 2020
  44. Shah P, Pellicori P, Kallvikbacka-Bennet A….Pan D, Clark AL. Warm water immersion in patients with chronic heart failure: a pilot study. Clinical Research in Cardiology 2019
  45. Zhang J, Pellicori P, Pan D et al. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology 2018
  46. Cuthbert JJ, Pellicori P, Rigby A, Pan D…Clark AL. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. European Journal of Heart Failure 2018
  47. Jackson C, Stagg HR, Doshi A, Pan D…Lipman M. Tuberculosis treatment outcomes among disadvantaged patients in India. Public Health Action 2017
  48. Appleton SC, Donnell DW, Singanayagam A, Pan D...Kon OM. Evaulation of prediagnosis emergency department presentations in patients with active tuberculosis: the role of chest radiography, risk factors and symptoms. BMJ Open Respiratory Research 2017
  49. Bua N, Smith GE, Totty JP, Pan D…Chetter IC. Dialkylcarbamoyl chloride dressings in the prevention of surgical site infections after nonimplant vascular surgery. Annals of Vascular Surgery 2017

Collaborative papers

  1. The RECOVERY collaborative. Immunomodulator therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child and Adolescent Health 2024
  2. The RECOVERY collaborative. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 2021
  3. The RECOVERY collaborative. Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial The Lancet Respiratory Medicine 2021
  4. The RECOVERY collaborative. Casivirimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet 2022
  5. The RECOVERY collaborative. Baracitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis. The Lancet 2022
  6. East Midlands Respiratory Virus Research Collaborative. Mitigating the return of acute respiratory virus infection. BMJ 2023
  7. COV-BOOST collaborative. Corrigendum to “Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial”. Journal of Infection 2023
  8. The RECOVERY collaborative. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic by not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label platform trial. The Lancet 2023
  9. The RECOVERY collaborative. Emplagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology 2023
  10. The RECOVERY collaborative. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child and Adolescent Health 2024


  1. Nazareth K, Baggaley RF, Divall P, Pan D…Pareek M. What is the evidence on existing national policies and guidelines for delivering effective tuberculosis, HIV and viral hepatitis services for refugees and migrants among Member States of the WHO European Region? WHO Evidence Network Synthesis Report 2022


  1. Al-Oraibi A, Naidu J, Chaka A…Pan D…Pareek M. Prevalence of long-COVID among healthcare workers: a systematic review and meta-analysis. BMJ Open 2022

Viewpoints/Editorials/Narrative Reviews

  1. Pan D, Nishimura H, Tang J. Information bias for case-definitions and mortality between, and within studies over time undermines out understanding of COVID-19 transmission and disease severity. Clinical Microbiology and Infection 2024
  2. Irizar P*, Pan D*, Taylor H. Disproportionate infection, hospitalisation and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical framework. EClinicalMedicine 2023
  3. Pan D, Hui DS, Tang JW. Defining infection transmission pathways for future pandemic preparedness – an urgent public health research priority. Journal of Infection 2023
  4. Pan D, Tang JW. Four key problems that will need to be addressed during the next pandemic. Clinical Medicine 2023
  5. Pan D, Sze S, Irizar P et al. Are clinical outcomes from COVID-19 improving in ethnic minority groups? EClinicalMedicine 2023
  6. Pan D, Pareek M. Towards an universal definition of long COVID- how do we proceed? JAMA Open Network 2023
  7. Pan D, Nazareth J, Sze S et al. Transmission of MPXV: a narrative review of environmental, viral, host and population factors in relation to the international 2022 outbreak. Journal of Medical Virology 2023
  8. Baggaley RF, Nazareth J, Divall P, Pan D…Pareek M. National policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for migrants among Member States of the WHO European Region. Journal of Travel Medicine 2022
  9. Nazareth J, Pan D, Martin CA et al. Is the UK prepared for the return of seasonal influenza in 2022-3 and beyond? The Lancet Infectious Diseases 2022
  10. Sze S, Pan D, Moss AJ et al. Overstimulation of the ergoreflex – a possible mechanism to explain symptoms in long COVID Frontiers in Cardiovascular Medicine 2022
  11. Pan D, Sze S, Nazareth J et al. Monkeypox in the UK  - arguments for a broader case definition drawing on lessons learnt during COVID-19. The Lancet 2022
  12. Barker J, Koeckerling D, Mudalige NL…Pan D. Awake prone positioning for patients with covid-19 – it’s a matter of time. British Medical Journal 2022
  13. Qureshi I, Gogoi M, Al-Oraibi A…Pan D…Nellums L. Intersectionality and developing evidence-based policy: Lessons learned? The Lancet 2022
  14. Pan D, Sze S, Martin CA et al. COVID-19 and ethnicity: we must seek to understand the drivers of higher transmission. British Medical Journal 2021
  15. Pan D, Mudalige NL, Sze S et al. The new UK SARS-CoV-2 variant and lockdown – causes and consequences. Clinical Medicine 2021
  16. Pan D, Sze S, Martin CA et al. COVID-19 and the new variant strain in England – what are the implications for those from ethnic minority groups? EClinicalMedicine 2021
  17. Sze S, Pan D, Williams CML et al. The need for improved discharge criteria for hospitalised patients with COVID-19- implications for patients in long-term care facilities. Age and Ageing 2021
  18. Teranaka W, Pan D. Discharge Criteria for patients with COVID-19 to long-term care facilities requires modification. Clinical Medicine 2021
  19. Minhas JS, Pan D, Sze S. COVID-19 pandemic personal development plan: a model for maximising higher specialty training. Future Healthcare Journal 2020
  20. Lim NTY, Pan D, Barker J. NEWS2 system requires modification to identify deteriorating patients with COVID-19. Clinical Medicine Journal 2020
  21. Koeckerling D, Barker J, Mudalige NL…Pan D…Ng GA. Awake prone positioning in COVID-19. Thorax 2020
  22. Barker J, Oyefeso O, Koeckerling D…Pan D. COVID-19: community CPAP and NIV should be stopped unless medically necessary to support life. Thorax 2020
  23. Pareek M, Bangash MN, Pareek N, Pan D…Khunti K. Ethnicity and COVID-19: an urgent public health research priority. The Lancet 2020
  24. Pellicori P, Salekin D, Pan D, Clark AL. This patient is not breathing properly: is this COPD, heart failure or neither? Expert Review of Cardiovascular Therapy 2017

Case reports

  1. Selvaskandan H, Hull K, Gregory R, Pan D…Bell R. Acute respiratory distress syndrome driven by severe hypercalcaemia and acute kidney injury: a case report and literature review of a rare, life-threatening complication. Clinical Nephrology 2022
  2. Pan D, Bridges LR, Parcq J et al. A rare cause of left-sided weakness in an elderly woman: amoebic encephalitis. The Lancet 2020
  3. Pan D, Arkell P, Stone NRH et al. Delayed Strongyloides stercoralis hyperinfection syndrome in a renal transplant patient with Pneumocystis jirovecii pneumonia receiving high-dose corticosteroids. The Lancet 2019
  4. Pan D, Bouligand J, Guichon-Mantel A, Adams D. FAP in India: a first genetically proven case. Orphanet Journal of Rare Diseases 2015
  5. Pan D, Cufari ME, Lim E. Beware of arteria lusoria during lymph node dissection of the right paratracheal fossa for lung cancer surgery. Journal of Thoracic Disease 2014

Correspondence to manuscripts

  1. Pan D, Choi JS, Martin CA et al. Quantifying the effect of vaccination on transmission in modelling studies. EClinicalMedicine 2024
  2. Pan D, Sze S, Nazareth J et al. The monkeypox case definition in the UK is broad - Authors' reply. The Lancet 2022
  3. Pan D, Martin CA, Nazareth J et al. Ethnic disparities in COVID-19: increased risk of infection or severe disease? The Lancet 2021
  4. Pan D, Sze S, Abraham S et al, Rapid tests for the quantification of infectiousness are required in patients with COVID-19. The Lancet Microbe 2021 
  5. Koeckerling D, Pan D, Barker J. Re:Efficacy and safety of tociluzumab in COVID-19 patient: a living systematic review and meta-analysis’ by Tleyjeh et al. Clinical Microbiology and Infection 2021
  6. Pan D, Sze S, Nevill CR et al. Authors’ reply: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis EClinicalMedicine 2021
  7. Pan D, Sze S, Minhas JS et al. Frailty and mortality in patients with COVID-19. The Lancet Pubic Health 2021
  8. Pan D. UK should consider a more cautious approach to PPE. BMJ 2020
  9. Pan D, Wong N, Toovey O et al. Reply to: A multicentre longitudinal cohort study of cryptococcosis in Human Immunodeficiency Virus-negative people in the United States. Clinical Infectious Diseases 2020
  10. Koeckerling D, Pan D, Mudalige NL et al. Blood transfusion strategies and ECMO during the COVID-19 pandemic. The Lancet Respiratory Medicine 2020
  11. Pan D, Zhang L, Pereira AC. Considerations in assessing disability trajectories before and after stroke and myocardial infarction. JAMA Neurology 2018


My PhD research is supervised by Professor Manish Pareek, Professor Mike Barer, Professor Laura Gray at the University of Leicester and externally, Professor T Déirdre Hollingsworth from the University of Oxford.


My position at the University of Leicester involves teaching on the Special Study Module for Infectious Diseases – this is for medical students at the University of Leicester as part of their final year curriculum. I have been involved for the administration of the course, from student selection to arrangement of the teaching timetable, as well as teaching the students in most aspects of infectious diseases for the undergraduate medical curriculum. I also teach and provide assessments for students on the MSc in Infection & Immunity course. Finally, I regularly teach and mentor students on the Global Health and Humanitarian Course ran by Médecins Sans Frontières; students from this course sit the Diploma in Tropical Medicine and Hygiene.

I have throughout my career to date had a teaching commitment.  I am experienced in teaching medical students and membership candidates in both general medicine and infectious diseases. I regularly lecture candidates for the MRCP and take groups of medical students regularly when on clinical duty.  I have previously established formal weekly teaching sessions for the junior medical staff at Leicester Royal Infirmary and have continued to take an active interest in teaching students and postgraduates in my present job, as well as nurses and other members of the multidisciplinary team. 


Press and media

Please get in touch for media enquiries, expert opinion, interviews, images or video.


  • Innovative Teacher of the Year – Hull York Medical School 2017
  • Best Oral Presentation – Rwandan International Scientific Week 2017
  • Best Moderated Poster – European Society of Cardiology World Congress 2018
  • Turner-Warwick Lectureship (Yorkshire) – Royal College of Physicians 2019
  • Best Oral Presentation – Royal Society of Medicine 2021
  • ‘30 under 30’ innovators in Science and Healthcare – Forbes magazine 2021
  • Winter Meeting Conference Grant for highest scoring abstract – British Thoracic Society 2021
  • Travel Grant for top 100 abstracts from ESCMID Young Scientist– European Congress of Clinical Microbiology and Infectious Diseases 2022
  • Travel Grant for outstanding abstract submitted to a conference – British Infection Association 2022
  • ‘COVID-19 changemaker’ nominated as an individual who went the extra mile to support others during COVID-19 – University of Leicester 2022
  • Travel grant for outstanding abstract submitted to a conference - Healthcare Infection Society 2023
  • Distinction MRes in Clinical Sciences, University of Leicester 2023. Highest overall score and score for dissertation in cohort
  • Travel Grant for outstanding abstract submitted to Federation of Infection Societies Conference 2023 - Microbiology Society
  • Turner-Warwick Lectureship (East Midlands) - Royal College of Physicians 2023
  • Travel grant for outstanding abstract submitted to Federation of Infection Societies Conference 2023 – British Infection Association 2023
  • Best PhD Presentation – Department of Respiratory Sciences, University of Leicester 2024
  • Best quickfire presentation – NIHR BRC Joint Respiratory Research Day, University of Leicester and University of Nottingham 2024
  • Nominated Full Member of Sigma XI, The Scientific Research Honor Society 2024
  • Best 3-minute thesis presentation, University of Leicester 2024

Media coverage

My research has been the topic of multiple news outlets, including the BBC.


2023     University of Leicester, MRes in Clinical Sciences

2020     Royal College of Physicians, Speciality Certificate Examination, Acute Medicine

2019     Royal College of Physicians, Diploma in Tropical Medicine and Hygiene

2019     Royal College of Physicians, MRCP

2018     University of York, Postgraduate Certificate in Health Research and Statistics

2015     Imperial College London, MBBS

2013     Imperial College London, BSc (Medical Sciences)

Back to top